Live Tuesday 15th October- Wednesday 16th October 2024
With access to accredited recordings until 15th December 2024
Let’s talk Clots virtual conference is for all UK healthcare professionals seeking to extend the understanding and practice in VTE prevention, management and achieving best outcomes for patients.
You will be joining a free, 24/7 accessible immersive learning environment offering updates, what’s new, on the horizon as well as opportunity to share and participate.
Seeking network links, collaboration and discussion? LTC’24 has it all.
Interact with leading UK professional organisations, join small group discussion, access webinars, case studies, live Q&A and enjoy full access to the Exhibition Hall.
LTC’24 is accessible 24/7 from 15th October 2024 – 15th December 2024.
Venous thromboembolism can affect anyone regardless of age, gender, race, or ethnicity
Studies of patients who die unexpectedly of pulmonary embolism reveal that they complained of nagging symptoms often for weeks before death related to pulmonary embolism.
References
1. Safi M, Rostami RT, Taherkhani M. Unusual presentation of a massive pulmonary embolism. J Tehran Heart Cent. 2011 Winter;6(1):41-4. Epub 2011 Feb 28. PMID: 23074604; PMCID: PMC3466862.
2. Kline JA, Runyon MS. Pulmonary embolism and deep venous thrombosis. In: Marx JA, Hockenberger RS, Walls RM, editors. Rosen’s Emergency Medicine Concepts and Clinical Practice. 6th ed. London: mosby; 2006. pp. 1368–1382
World Thrombosis Day is recognised globally on October 13 and seeks to focus attention on the often overlooked and misunderstood condition of thrombosis.
Thrombosis UK, a UK registered charity, is proud to support World Thrombosis Day and join this movement to place a global spotlight on blood clots as an urgent and growing health problem.
Thrombosis UK invites you to share your research with thousands of colleagues attending our flagship conference – NTW’25, 7-9 May 2025.
Accepted Posters will be displayed within the NTW’25 conference platform and accessible to view by all registered attendees from 7th May 2025. Up to eight submissions will be selected and invited to provide an oral presentation within the main NTW’25 agenda or be part of a round table panel discussion.
For full information on how to submit your abstract and e-poster.
Discover the latest insights, innovations and testimonials
Translating thrombosis risk to individualised prevention
Prevention of hospital associated thrombosis in NHS England - why we do central VTE prevention collection and why it has therefore started again.
What are we going to do about VTE prevention in pregnancy and puerperium?
Why might we struggle to detect VTE in primary care?
Point of care ultrasound using AI
- Improving compliance of VTE prophylaxis patients admitted in the hospital
- Improving medical student's understanding and confidence at managing VTE
- Factoring patients’ beliefs and values into decisions around anticoagulation: a community-led multi-cycle quality improvement project.
What's new and on the horizon in anticoagulation for the prevention and treatment of VTE?
Intermittent Pneumatic Compression; current guidance and clinical evidence
Management Strategies for DOAC-Related Life Threatening Bleeds
This is an AstraZeneca sponsored promotional symposium at which AstraZeneca products will be discussed. This meeting is intended for UK healthcare professionals only.
Evaluating the potential benefit of Graduated Compression Stockings in addition to extended duration pharmacological thromboprophylaxis for surgical patients at highest risk of venous thromboembolism.
Sponsoring companies have no input into the conference agenda, speaker selection or presentations with the exception of sponsored symposia sessions, for which the respective sponsoring company is fully responsible.
If you would like to find out about opportunities to sponsor the LTC’24 virtual conference for healthcare professionals, please email: jo@thrombosisuk.org .
AstraZeneca has provided sponsorship towards this independent Programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence, except for the AstraZeneca sponsored symposium presentation.